BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,130,000 | -31.3% | 82,959 | +0.4% | 0.00% | -50.0% |
| Q3 2016 | $1,644,000 | +53.2% | 82,628 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $1,073,000 | +284.6% | 82,773 | +177.7% | 0.00% | – |
| Q1 2016 | $279,000 | -53.0% | 29,811 | +1.8% | 0.00% | -100.0% |
| Q4 2015 | $594,000 | +42.4% | 29,287 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $417,000 | -34.9% | 28,730 | -4.7% | 0.00% | 0.0% |
| Q2 2015 | $641,000 | +11.1% | 30,149 | +21.1% | 0.00% | 0.0% |
| Q1 2015 | $577,000 | – | 24,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |